Oklahoma Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 19 (90% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 7,586
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 44.12%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 3,290
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 49.59%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 49.26% 43.50%
White, Hispanic/Latino Patients 23.56% 27.23%
Black/African American, Non-Hispanic/Latino Patients 4.88% 5.17%
Black/African American, Hispanic/Latino Patients 0.24% 0.24%
Asian Patients3 0.54% 0.49%
American Indian/Alaska Native Patients3 4.69% 4.56%
Native Hawaiian/Other Pacific Islander Patients3 0.17% 0.12%
Patients with More Than One Race3 1.92% 1.91%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.90% 3.07%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.51% 7.42%
Unreported/Refused to Report Race and Ethnicity 6.33% 6.29%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,212
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 82.14%
COVID-19 Immunization Series Completed 239
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 63.21%
COVID-19 Immunization Series Additional 1,113
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 43.23%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 16.01% 32.64% 44.47%
White, Hispanic/Latino Patients 58.99% 38.91% 21.47%
Black/African American, Non-Hispanic/Latino Patients 4.21% 7.11% 3.95%
Black/African American, Hispanic/Latino Patients 0.33% 0.42% 0.09%
Asian Patients3 0.83% 1.26% 1.62%
American Indian/Alaska Native Patients3 1.32% 5.44% 1.62%
Native Hawaiian/Other Pacific Islander Patients3 0.58% 0.00% 0.18%
Patients with More Than One Race3 0.58% 0.84% 2.70%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.77% 2.09% 2.25%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.43% 3.77% 4.49%
Unreported/Refused to Report Race and Ethnicity 2.97% 7.53% 17.16%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 26.32%
1 to 24 Hours 21.05%
More Than 24 Hours 52.63%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 10.53%
Staffing to administer the vaccine 52.63%
Vaccine confidence 36.84%
Vaccine storage capacity 5.26%
Vaccine supply 5.26%
Other 0.00%
None 15.79%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 10.53%
Average Percent of Health Center Visits Conducted Virtually 16.58%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 15.79%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 2
Number of School-Based Vaccination Sites 6
Number of Family Vaccination Clinics 12

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 57.89%
None 42.11%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 5.26%
Patient awareness/education 15.79%
Staffing capacity 21.05%
Therapy administration/onsite logistics 31.58%
Other 0.00%
None 57.89%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 4
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 2,228

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 50.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 25.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 0.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022